A photo of Adam Nelson.

Member, Division of Bone Marrow Transplantation and Immune Deficiency

Assistant Professor, UC Department of Pediatrics



About Me


I specialize in the care of patients with bone marrow failure syndromes and those who require bone marrow transplants. I am also interested in the use of cellular therapy, particularly to prevent and treat viral infections in patients before or after transplant. I consider it a privilege to work with such a multidisciplinary team to deliver the best care for my patients.

I always wanted to work with children because any care we can give them early in life can have a huge impact in helping them live normal lives. I was particularly drawn to bone marrow transplant, as this field is constantly changing and adapting as new scientific breakthroughs are discovered. I value getting to follow my patients for the rest of their lives and see them grow up and have children of their own.

Originally from Australia, I came to Cincinnati Children’s thinking I would only be here for a year. But after seeing the wonderful care delivered here, I was fortunate enough to stay and continue to work with our dedicated team.

In my practice, I enjoy being an integral part of my patient's journey and accommodating the needs of the entire family throughout their treatment. I align the needs of my patients with the best clinical practices and the most up-to-date treatments available to ensure a good outcome.

When I’m not treating patients, I’m doing research. I received an award from the Fanconi Anemia Research Fund to investigate how to prevent the development of cancer in patients affected by Fanconi anemia, a disease that affects bone marrow. My colleagues and I are also looking at ways to prevent bone marrow failure (BMF), to treat some of the complications of BMF syndromes and to develop new targeted strategies to minimize toxicity associated with treatments. Additionally, we are working on ways to use T cells to prevent and treat new viral infections in patients with weakened immune systems, either after bone marrow transplant or after receiving a solid organ transplant.

When I’m not at work, I like spending time with family and friends. I also enjoy keeping active and occasionally doing 24-hour trail runs with like-minded crazy friends.

Academic Affiliation

Assistant Professor, UC Department of Pediatrics


Bone Marrow Transplantation BMT, Cancer and Blood Diseases, Langerhans Cell Histiocytosis, Fanconi Anemia, Immune Deficiencies and Histiocytosis

My Locations

My Education

BMedSci: University of Sydney, Australia, 2002.

MBBS(Hons): University of Sydney, Australia, 2006.

Residency: Sydney Children's Hospital, Australia, 2011.

Fellowship: Sydney Children's Hospital, Australia, 2014.

BMT Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2015.

My Publications

Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab. Jodele, S; Dandoy, CE; Lane, A; Laskin, BL; Laskin, B; Teusink-Cross, A; Myers, KC; Wallace, G; Nelson, AS; Nelson, A; et al. Blood. 2020; 26:S138-S138.

EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defects. Rubinstein, JD; Burns, K; Absalon, M; Lutzko, C; Leemhuis, T; Chandra, S; Hanley, PJ; Keller, MD; Davies, SM; Nelson, A; et al. Pediatric Blood and Cancer. 2020; 67.

High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy. Lee, LH; Krupski, C; Clark, J; Wunderlich, M; Lorsbach, RB; Grimley, MS; Burwinkel, M; Nelson, A; Kumar, AR. Blood Advances. 2020; 4:717-727.

CD38brightCD8+ T Cells Associated with the Development of Acute GVHD Are Activated, Proliferating, and Cytotoxic Trafficking Cells. Khandelwal, P; Chaturvedi, V; Owsley, E; Lane, A; Heyenbruch, D; Lutzko, CM; Leemhuis, T; Grimley, MS; Nelson, AS; Davies, SM; et al. Biology of Blood and Marrow Transplantation. 2020; 26:1-6.

Pediatric and Young Adult Vulvovaginal Graft-versus-Host Disease. Cizek, SM; El-Bietar, J; Rubinstein, J; Dandoy, C; Wallace, GH; Nelson, A; Khandelwal, P; Myers, KC; Hoefgen, HR. Biology of Blood and Marrow Transplantation. 2019; 25:2408-2415.

Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Dandoy, CE; Kelley, T; Gaur, AH; Nagarajan, R; Demmel, K; Alonso, PB; Guinipero, T; Savelli, S; Hakim, H; Owings, A; et al. Pediatric Blood and Cancer. 2019; 66.

Reduction in Nephrotoxic Antimicrobial Exposure Decreases Associated Acute Kidney Injury in Pediatric Hematopoietic Stem Cell Transplant Patients. Benoit, SW; Goldstein, SL; Dahale, DS; Haslam, DB; Nelson, A; Truono, K; Davies, SM. Biology of Blood and Marrow Transplantation. 2019; 25:1654-1658.

Xenon-129 MRI detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry. Walkup, LL; Myers, K; El-Bietar, J; Nelson, A; Willmering, MM; Grimley, M; Davies, SM; Towe, C; Woods, JC. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology. 2019; 53:1801779-1801779.

Understanding the evolving phenotype of vascular complications in telomere biology disorders. Higgs, C; Crow, YJ; Adams, DM; Chang, E; Jr, HD; Herbig, U; Huang, JN; Himes, R; Jajoo, K; Johnson, FB; et al. Angiogenesis. 2019; 22:95-102.

The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. Thakar, MS; Broglie, L; Logan, B; Artz, A; Bunin, N; Burroughs, LM; Fretham, C; Jacobsohn, DA; Loren, AW; Kurtzberg, J; et al. Blood. 2019; 133:754-762.